TheraRadar
Data updated: May 26, 2026

TRIFLUOPERAZINE HCL (trifluoperazine hydrochloride)

CNS

Details

Status
Discontinued
First Approved
N/A
Routes
Injection
Dosage Forms
Injectable

Companies

Active Ingredient: TRIFLUOPERAZINE HYDROCHLORIDE

TRIFLUOPERAZINE HCL Approval History

No approval records found
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

TRIFLUOPERAZINE HCL FDA Label Details

Track TRIFLUOPERAZINE HCL with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.